Ixazomib (NINLARO®) capsules / Matching placebo capsules
012436
Phase 1 small_molecule active
Quick answer
Ixazomib (NINLARO®) capsules / Matching placebo capsules for Relapsing Remitting Multiple Sclerosis is a Phase 1 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Relapsing Remitting Multiple Sclerosis
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active